Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12 studies found for:    "Erythropoietic protoporphyria"
Show Display Options
Rank Status Study
1 Unknown  Phase III Confirmatory Study in Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
2 Completed Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
3 Completed Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
4 Withdrawn Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
Conditions: Erythropoietic Protoporphyria (EPP);   X Linked Erythropoietic Protoporphyria
Intervention: Drug: Isoniazid
5 Completed Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
6 Active, not recruiting Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
Condition: Erythropoietic Protoporphyria (EPP)
Intervention:
7 Completed Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
8 Unknown  Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Behavioral: exercise;   Behavioral: heat;   Procedure: red light illumination
9 Recruiting Oral Iron for Erythropoietic Protoporphyrias
Conditions: Erythropoietic Protoporphyria;   EPP;   X-linked Protoporphyria;   XLP
Intervention: Drug: Oral Iron
10 Recruiting Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Conditions: Erythropoietic Protoporphyria;   EPP;   X-Linked Protoporphyria;   XLP;   XLPP;   X-Linked Dominant Erythropoietic Protoporphyria;   XLEPP;   XLDP
Intervention:
11 Completed Sorbent Therapy of the Cutaneous Porphyrias
Condition: Erythropoietic Protoporphyria
Intervention: Drug: Colestipol
12 Recruiting Longitudinal Study of the Porphyrias
Conditions: Acute Porphyrias;   Cutaneous Porphyrias
Intervention:

Study has passed its completion date and status has not been verified in more than two years.